From €1998EUR$2,100USD£1,701GBP
€2854EUR$3,000USD£2,429GBP
From €3030EUR$3,185USD£2,579GBP
€4329EUR$4,550USD£3,685GBP
- Report
- April 2023
- 120 Pages
Global
From €4519EUR$4,750USD£3,846GBP
- Report
- January 2022
- 200 Pages
Global
From €7135EUR$7,500USD£6,073GBP
- Report
- January 2022
- 60 Pages
Global
From €3758EUR$3,950USD£3,199GBP
- Report
- March 2023
- 119 Pages
Global
From €4661EUR$4,900USD£3,968GBP
- Report
- August 2022
- 116 Pages
Global
From €4281EUR$4,500USD£3,644GBP
- Report
- June 2022
- 244 Pages
Global
From €3030EUR$3,185USD£2,579GBP
€4329EUR$4,550USD£3,685GBP
- Report
- July 2020
- 116 Pages
North America
From €1998EUR$2,100USD£1,701GBP
€2854EUR$3,000USD£2,429GBP
- Report
- July 2020
- 128 Pages
Europe
From €1998EUR$2,100USD£1,701GBP
€2854EUR$3,000USD£2,429GBP
- Report
- July 2020
- 132 Pages
Asia Pacific
From €1998EUR$2,100USD£1,701GBP
€2854EUR$3,000USD£2,429GBP
- Report
- July 2019
- 72 Pages
Global
From €3092EUR$3,250USD£2,632GBP
- Report
- November 2020
- 120 Pages
Global
From €2378EUR$2,500USD£2,024GBP
- Report
- August 2022
United States
From €1846EUR$1,940USD£1,571GBP
- Report
- August 2022
Global
From €942EUR$990USD£802GBP
- Report
- August 2021
Global
From €3796EUR$3,990USD£3,231GBP
- Report
- August 2021
Europe
From €3254EUR$3,420USD£2,769GBP
- Report
- November 2022
- 100 Pages
Global
From €3758EUR$3,950USD£3,199GBP
- Report
- March 2022
- 304 Pages
Global
From €2378EUR$2,500USD£2,024GBP
- Clinical Trials
- December 2021
- 295 Pages
Global
From €2378EUR$2,500USD£2,024GBP
The Diabetic Foot Ulcer Drug market is a segment of the Wound Care industry that focuses on the treatment of diabetic foot ulcers. These ulcers are a common complication of diabetes, and can lead to serious infections and even amputation if left untreated. Treatment typically involves the use of topical medications, such as antibiotics, antifungals, and growth factors, as well as offloading devices to reduce pressure on the ulcer.
The Diabetic Foot Ulcer Drug market is highly competitive, with a range of products available from both large and small companies. Many of these companies are actively developing new treatments, such as advanced wound dressings and biologics, to improve outcomes for patients.
Some of the major companies in the Diabetic Foot Ulcer Drug market include Smith & Nephew, Mölnlycke Health Care, ConvaTec, Coloplast, and BSN Medical. Show Less Read more